Cardio-oncology & otherCohort study

Disproportionate Risk of Cancer Following Diagnosis of Peripheral Artery Disease

JACC AdvPublished

  • retrospective cohort study
  • inverse probability of treatment-weighted Fine-Gray subdistribution hazard model
  • MarketScan Research Database (2013-2023)

Authors' conclusion

Patients with PAD experience a higher risk of multiple forms of cancer after controlling for shared risk factors.

Study context

Population
Adults aged ≥40 years with ≥36 months of continuous coverage in the MarketScan Research Database (2013–2023)Peripheral arterial disease (PAD) 87,594 · non-PAD CVD 917,680 · without CVD 4,303,899
Participants
87,594 / 917,680 / 4,303,899
Exposure
PAD vs non-PAD CVD and vs no CVD
  • PADn = 87,594
  • non-PAD CVDn = 917,680
  • no CVDn = 4,303,899
Outcome
time to incident cancer

Main finding

As reported in the abstract

multivariable-adjusted inverse probability of treatment-weighted
Subdistribution hazard ratio (95% CI)P value
PAD vs non-PAD CVD
1.027(1.001–1.053)
P = 0.044
PAD vs no CVD
1.158(1.129–1.187)
P < 0.0001

Observational data: associations, not effects.

Further findings

20 most common cancers (individual analysis)

associations of PAD with specific malignancies

Original publication

Disproportionate Risk of Cancer Following Diagnosis of Peripheral Artery Disease. JACC Adv. Published 15 June 2026. doi:10.1016/j.jacadv.2026.102889

Summarised from the published abstract; every number is checked against it